Constellium N.V. Announces Delisting From Euronext Paris
Jan 31, 2018 07:00 am UTC| Business
AMSTERDAM, The Netherlands, Jan. 31, 2018 -- Constellium N.V. (NYSE:CSTM) (Euronext Paris:CSTM) (« Constellium ») today announced that the request by Constellium to delist its shares (ISIN: NL0010489522) from Euronext...
New NXP CAN Transceiver Family Secures CAN Communications Without Cryptography
Jan 31, 2018 07:00 am UTC| Business
SHANGHAI, China, Jan. 31, 2018 -- NXP Semiconductors (NASDAQ:NXPI), the world’s largest supplier of automotive semiconductors1, today announced a new secure CAN transceiver family that offers a seamless, efficient...
Courtyard Sydney-North Ryde Unveils Complete Transformation
Jan 31, 2018 06:56 am UTC| Business
NORTH RYDE, Sydney, Jan. 31, 2018 -- A brand-new North Ryde accommodations experience awaits guests of the recently-refreshed Courtyard Sydney-North Ryde hotel. Following its $2.7 million AUD renovation, the hotel in...
ArcelorMittal reports fourth quarter 2017 and full year 2017 results
Jan 31, 2018 06:01 am UTC| Business
Luxembourg, January 31, 2018 - ArcelorMittal (referred to as "ArcelorMittal" or the "Company") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company, today...
INNATE PHARMA : Prof. Jean-Yves Blay appointed to the Innate Pharma Supervisory Board
Jan 31, 2018 06:01 am UTC| Business
Prof. Jean-Yves Blay appointed to the Innate Pharma Supervisory Board Marseille, France, January 31, 2018, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today...
Gemalto's Discovery Service boosts on-demand connectivity activation for consumer devices worldwide
Jan 31, 2018 06:01 am UTC| Business
The new solution allows users to easily activate their mobile subscription of their eSIM-enabled consumer IoT devices Austin, TX, 31 January 2018 - Gemalto, the world leader in digital security, announces its new...
ASLAN Pharmaceuticals Sponsors Cholangiocarcinoma Foundation Annual Conference 2018
Jan 31, 2018 06:00 am UTC| Business
SINGAPORE, Jan. 31, 2018 -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and...